Journal of Preventive Medicine and Public Health

The Korean Society for Preventive Medicine (대한예방의학회)
권호 표지
DOI QR코드

DOI QR Code

Areca Nut Chewing and the Risk of Re-hospitalization and Mortality Among Patients With Acute Coronary Syndrome in Pakistan

  • Karim, Muhammad Tariq (Research Evaluation Unit, College of Physicians and Surgeons Pakistan) ;
  • Inam, Sumera (School of Public Health, Dow University of Health Sciences) ;
  • Ashraf, Tariq (National Institute of Cardiovascular Diseases) ;
  • Shah, Nadia (School of Public Health, Dow University of Health Sciences) ;
  • Adil, Syed Omair (Department of Research, Dow University of Health Sciences) ;
  • Shafique, Kashif (School of Public Health, Dow University of Health Sciences)
  • Received : 2017.11.17
  • Accepted : 2018.01.12
  • Published : 2018.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: Areca nut is widely consumed in many parts of the world, especially in South and Southeast Asia, where cardiovascular disease (CVD) is also a huge burden. Among the forms of CVD, acute coronary syndrome (ACS) is a major cause of mortality and morbidity. Research has shown areca nut chewing to be associated with diabetes, hypertension, oropharyngeal and esophageal cancers, and CVD, but little is known about mortality and re-hospitalization secondary to ACS among areca nut users and non-users. Methods: A prospective cohort was studied to quantify the effect of areca nut chewing on patients with newly diagnosed ACS by categorizing the study population into exposed and non-exposed groups according to baseline chewing status. Cox proportional hazards models were used to examine the associations of areca nut chewing with the risk of re-hospitalization and 30-day mortality secondary to ACS. Results: Of the 384 ACS patients, 49.5% (n=190) were areca users. During 1-month of follow-up, 20.3% (n=78) deaths and 25.1% (n=96) re-hospitalizations occurred. A higher risk of re-hospitalization was found (adjusted hazard ratio [aHR], 2.05; 95% confidence interval [CI], 1.29 to 3.27; p=0.002) in areca users than in non-users. Moreover, patients with severe disease were at a significantly higher risk of 30-day mortality (aHR, 2.77; 95% CI, 1.67 to 4.59; p<0.001) and re-hospitalization (aHR, 2.72; 95% CI, 1.73 to 4.26; p<0.001). Conclusions: The 30-day re-hospitalization rate among ACS patients was found to be significantly higher in areca users and individuals with severe disease. These findings suggest that screening for a history of areca nut chewing may help to identify patients at a high risk for re-hospitalization due to secondary events.

Keywords

References

  1. Pankaj C. Areca nut or betel nut control is mandatory if India wants to reduce the burden of cancer especially cancer of the oral cavity. Int J Head Neck Surg 2010;1(1):17-20.
  2. Gupta PC, Ray CS. Epidemiology of betel quid usage. Ann Acad Med Singapore 2004;33(4 Suppl):31-36.
  3. Niaz K, Maqbool F, Khan F, Bahadar H, Ismail Hassan F, Abdollahi M. Smokeless tobacco (paan and gutkha) consumption, prevalence, and contribution to oral cancer. Epidemiol Health 2017;39:e2017009.
  4. Boucher BJ, Mannan N. Metabolic effects of the consumption of areca catechu. Addict Biol 2002;7(1):103-110. https://doi.org/10.1080/13556210120091464
  5. Wollina U, Verma S, Parikh D, Parikh A. Oral and extraoral disease due to betel nut chewing. Hautarzt 2002;53(12):795-797 (German). https://doi.org/10.1007/s00105-002-0413-1
  6. Sciubba JJ. Oral cancer. The importance of early diagnosis and treatment. Am J Clin Dermatol 2001;2(4):239-251. https://doi.org/10.2165/00128071-200102040-00005
  7. Tsai JF, Jeng JE, Chuang LY, Ho MS, Ko YC, Lin ZY, et al. Habitual betel quid chewing and risk for hepatocellular carcinoma complicating cirrhosis. Medicine (Baltimore) 2004;83(3):176-187. https://doi.org/10.1097/01.md.0000126971.80227.a4
  8. Wu IC, Lu CY, Kuo FC, Tsai SM, Lee KW, Kuo WR, et al. Interaction between cigarette, alcohol and betel nut use on esophageal cancer risk in Taiwan. Eur J Clin Invest 2006;36(4):236-241. https://doi.org/10.1111/j.1365-2362.2006.01621.x
  9. Hsiao TJ, Liao HW, Hsieh PS, Wong RH. Risk of betel quid chewing on the development of liver cirrhosis: a community-based case-control study. Ann Epidemiol 2007;17(6):479-485. https://doi.org/10.1016/j.annepidem.2006.12.007
  10. Yen AM, Chiu YH, Chen LS, Wu HM, Huang CC, Boucher BJ, et al. A population-based study of the association between betel-quid chewing and the metabolic syndrome in men. Am J Clin Nutr 2006;83(5):1153-1160. https://doi.org/10.1093/ajcn/83.5.1153
  11. Chung FM, Chang DM, Chen MP, Tsai JC, Yang YH, Shieh TY, et al. Areca nut chewing is associated with metabolic syndrome: role of tumor necrosis factor-alpha, leptin, and white blood cell count in betel nut chewing-related metabolic derangements. Diabetes Care 2006;29(7):1714.
  12. Chang WC, Hsiao CF, Chang HY, Lan TY, Hsiung CA, Shih YT, et al. Betel nut chewing and other risk factors associated with obesity among Taiwanese male adults. Int J Obes (Lond) 2006; 30(2):359-363. https://doi.org/10.1038/sj.ijo.0803053
  13. Tung TH, Chiu YH, Chen LS, Wu HM, Boucher BJ, Chen TH, et al. A population-based study of the association between areca nut chewing and type 2 diabetes mellitus in men (Keelung Community-based Integrated Screening programme No. 2). Diabetologia 2004;47(10):1776-1781. https://doi.org/10.1007/s00125-004-1532-2
  14. Chou CY, Cheng SY, Liu JH, Cheng WC, Kang IM, Tseng YH, et al. Association between betel-nut chewing and chronic kidney disease in men. Public Health Nutr 2009;12(5):723-727. https://doi.org/10.1017/S1368980008003339
  15. Shafique K, Zafar M, Ahmed Z, Khan NA, Mughal MA, Imtiaz F. Areca nut chewing and metabolic syndrome: evidence of a harmful relationship. Nutr J 2013;12:67. https://doi.org/10.1186/1475-2891-12-67
  16. Zhang LN, Yang YM, Xu ZR, Gui QF, Hu QQ. Chewing substances with or without tobacco and risk of cardiovascular disease in Asia: a meta-analysis. J Zhejiang Univ Sci B 2010;11(9):681-689. https://doi.org/10.1631/jzus.B1000132
  17. Khan MS, Bawany FI, Ahmed MU, Hussain M, Khan A, Lashari MN. Betel nut usage is a major risk factor for coronary artery disease. Glob J Health Sci 2013;6(2):189-195.
  18. Lan TY, Chang WC, Tsai YJ, Chuang YL, Lin HS, Tai TY. Areca nut chewing and mortality in an elderly cohort study. Am J Epidemiol 2007;165(6):677-683. https://doi.org/10.1093/aje/kwk056
  19. Lin WY, Chiu TY, Lee LT, Lin CC, Huang CY, Huang KC. Betel nut chewing is associated with increased risk of cardiovascular disease and all-cause mortality in Taiwanese men. Am J Clin Nutr 2008;87(5):1204-1211. https://doi.org/10.1093/ajcn/87.5.1204
  20. McClintock TR, Parvez F, Wu F, Wang W, Islam T, Ahmed A, et al. Association between betel quid chewing and carotid intima-media thickness in rural Bangladesh. Int J Epidemiol 2014; 43(4):1174-1182. https://doi.org/10.1093/ije/dyu009
  21. Heck JE, Marcotte EL, Argos M, Parvez F, Ahmed A, Islam T, et al. Betel quid chewing in rural Bangladesh: prevalence, predictors and relationship to blood pressure. Int J Epidemiol 2012; 41(2):462-471. https://doi.org/10.1093/ije/dyr191
  22. Yamada T, Hara K, Kadowaki T. Chewing betel quid and the risk of metabolic disease, cardiovascular disease, and all-cause mortality: a meta-analysis. PLoS One 2013;8(8):e70679. https://doi.org/10.1371/journal.pone.0070679
  23. Grech ED, Ramsdale DR. Acute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarction. BMJ 2003;326(7401):1259-1261. https://doi.org/10.1136/bmj.326.7401.1259
  24. Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002;23(15):1190-1201. https://doi.org/10.1053/euhj.2002.3193
  25. Tsai WC, Wu MT, Wang GJ, Lee KT, Lee CH, Lu YH, et al. Chewing areca nut increases the risk of coronary artery disease in Taiwanese men: a case-control study. BMC Public Health 2012; 12:162. https://doi.org/10.1186/1471-2458-12-162
  26. Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc 2009;84(10):917-938. https://doi.org/10.4065/84.10.917
  27. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363(9403):157-163. https://doi.org/10.1016/S0140-6736(03)15268-3
  28. Tseng CH. Betel nut chewing and subclinical ischemic heart disease in diabetic patients. Cardiol Res Pract 2010;2011: 451489.
  29. Al-Sharabi AK, Shuga-Aldin H, Ghandour I, Al-Hebshi NN. Qat chewing as an independent risk factor for periodontitis: a cross-sectional study. Int J Dent 2013;2013:317640.
  30. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum 2004;85:1-334.
  31. World Health Organization. Global status report on noncommunicable diseases 2010: description of the global burden of NCDs, their risk factors and determinants; 2011 [cited 2017 Apr 1]. Available from: http://www.who.int/nmh/publications/ncd_report2010/en/.
  32. Tsai WC, Chen CY, Kuo HF, Wu MT, Tang WH, Chu CS, et al. Areca nut chewing and risk of atrial fibrillation in Taiwanese men: a nationwide ecological study. Int J Med Sci 2013;10(7):804-811. https://doi.org/10.7150/ijms.5998
  33. Lin SH, Liao YS, Huang SH, Liao WH. Relationship between betel quid chewing and risks of cardiovascular disease in older adults: a cross-sectional study in Taiwan. Drug Alcohol Depend 2014;141:132-137.
  34. Shafique K, Mirza SS, Vart P, Memon AR, Arain MI, Tareen MF, et al. Areca nut chewing and systemic inflammation: evidence of a common pathway for systemic diseases. J Inflamm (Lond) 2012;9(1):22.
  35. Hashibe M, Jacob BJ, Thomas G, Ramadas K, Mathew B, Sankaranarayanan R, et al. Socioeconomic status, lifestyle factors and oral premalignant lesions. Oral Oncol 2003;39(7):664-671. https://doi.org/10.1016/S1368-8375(03)00074-5